What is Catalyst Clinical Research?
Catalyst Clinical Research operates as a premier clinical contract research organization, delivering innovative and adaptable solutions tailored for the biotech and biopharmaceutical industries. The company's specialized divisions, Catalyst Oncology and Catalyst Flex, offer comprehensive services for oncology drug development and functional service provision across multiple therapeutic areas. By leveraging experienced teams and a robust site network, Catalyst is committed to advancing cancer drug development and clinical trials, positioning itself as a vital partner for biotechnology firms seeking expertise in clinical operations and data management.
How much funding has Catalyst Clinical Research raised?
Catalyst Clinical Research has raised a total of $119M across 1 funding round:
Debt
$119M
Debt (2022): $119M with participation from MidCap Financial
Key Investors in Catalyst Clinical Research
MidCap Financial
MidCap Financial is a lender that provides flexible financing solutions, suggesting a focus on debt financing for established companies looking to scale operations or undertake significant projects.
What's next for Catalyst Clinical Research?
The substantial enterprise-level funding and recent strategic investment indicate Catalyst Clinical Research is poised for significant expansion and further integration of its innovative service offerings. This capital infusion is expected to fuel advancements in their clinical trial support, particularly within oncology, and enhance their functional service provider capabilities. The company's focus on flexibility and expertise suggests a strategic direction aimed at solidifying its role as a key partner for biopharmaceutical companies navigating complex drug development pathways.
See full Catalyst Clinical Research company page
